Boston University’s Antibody-Focused AI Skips the Warehouse, Goes Straight for the Key
Finding a therapeutic antibody that binds tightly to a specific disease target has traditionally meant screening millions, sometimes billions, of...
Finding a therapeutic antibody that binds tightly to a specific disease target has traditionally meant screening millions, sometimes billions, of...
Novo Nordisk, the Danish pharmaceutical giant behind Ozempic and Wegovy, announced on August 10, 2026, a sweeping strategic partnership with...
Rentosertib, a lung-disease drug whose molecular target was identified and whose structure was designed by generative AI, has been granted...
A single stained tissue slide, the kind pathologists have examined under microscopes for more than a century, can now be...
For three years, every major AI structure-prediction tool available to drug hunters has been trained to see something that, it...
A software company called UpDoc has begun rolling out what it describes as the first FDA-cleared clinical AI platform built...
An Atlanta-based health technology company called CheckWellCall has begun the commercial soft launch of an AI-powered daily wellness check-in platform...
With no federal framework yet governing AI chatbots that people turn to for mental health support, a growing patchwork of...
Every day across HCA Healthcare's 190 hospitals and roughly 2,400 ambulatory sites of care, nurses perform the same routine roughly...
At Temple University Hospital in North Philadelphia, an artificial intelligence program called EndoTool is now fully embedded in how nurses...